Workers’ Comprehensive

News and views in workers’ comp
Important news in workers’ comp delivered to your inbox
Subscribe

Search Workers' Comprehensive Articles

  • Reset
This Month's Must Read
Out of Balance: Workforce Gender Disparities and What They Mean for Workers’ Comp

Women workers were more adversely impacted by the pandemic and the recession.

Read More →
Marijuana Developments
Positive Marijuana Drug Screenings Reach All Time High

Quest Diagnostics reports increased positivity rates for marijuana in employee drug screenings.

Read More →
COVID-19 Developments
FDA Authorizes Second COVID-19 Booster Dose for Special Populations

Adults aged 50 and older and immunocompromised individuals may receive a second booster dose.

Read More →
Industry Trends
NCCI Reports on Return-to-Work Strategies

Carriers share their thoughts on successful RTW programs.

Read More →
Medmonitor
FDA Approves Fleqsuvy for Spasticity

A new muscle relaxant for the treatment of spasticity, including from spinal cord injuries.

Read More →
This Month's Must Read
2022 Workers’ Comp Industry Insights Survey Report

Nearly 500 stakeholders share their thoughts on industry challenges and priorities.

Read More →
Opioid Developments
CDC to Update Opioid Guideline

Proposed changes are open to public comment until April 11th.

Read More →
Legislation & Policy
First Responder PTSD Bills Return to the Forefront

After a drop in activity due to the pandemic, five states are now considering legislation.

Read More →
Healthe Developments
Five Things to Know About Workers’ Compensation Pharmacy Services

Healthe’s VP of Industry and State Affairs, Sandy Shtab, joined an educational webinar from IAIABC.

Read More →
Medmonitor
FDA Issues Warning for Dental Problems with Dissolvable Buprenorphine Products

Buprenorphine is an opioid used to treat pain, as well as opioid-use disorder.

Read More →
This Month's Must Read
Classification Complications: Will Gig Workers Enter the Workers’ Comp Market?

Legislation could potentially reclassify gig workers as employees entitled to workers’ comp.

Read More →
COVID-19 Developments
FDA Fully Approves Moderna Vaccine & Expands Veklury’s Treatment Range

Drug advancements surrounding the prevention and treatment of COVID-19.

Read More →
Legislation & Policy
Marijuana: States Move Forward Medically and Recreationally, But Oppose Reimbursement in Comp

Since the start of 2022, at least 10 states are considering some form of marijuana legislation.

Read More →
Healthe Developments
Claims Adjusters Are the Future Leaders of Workers’ Comp: How Can We Nurture Their Success?

Healthe’s Director of Product Management talks to Risk & Insurance on how to attract and retain talent in the workers’ comp industry.

Read More →
Medmonitor
FDA Approves Yusimry as a Biosimilar to Humira

This autoimmune drug was approved for various arthritic and autoimmune diseases.

Read More →
This Month's Must Read
The Top Priorities of the Workers’ Comp Industry for Future Resiliency

The initial results from a collaborative survey between Healthe and Risk & Insurance.®

Read More →
COVID-19 Developments
Additional Vaccine Candidate Performs Well in Clinical Trials

Phase 3 trials for NVX-CoV2373 across 30,000 people found this vaccine candidate to be safe and effective for the prevention of COVID-19.

Read More →
Clinical Insights
CDC Updates Isolation and Quarantine Period for COVID-19

New five-day rules are recommended, with variation depending upon vaccination status.

Read More →
Industry Trends
The Great Resignation Continues to Impact Workforce Dynamics

The Bureau of Labor Statistics reports that 4.5 million employees quit their jobs in November 2021.

Read More →
Healthe Developments
4 Ways to Manage Medical Supply Chain Disruption in Workers’ Comp

Healthe’s SVP of Product Strategy and Innovation, Kristine Kennedy, discusses this topic with Risk & Insurance magazine.

Read More →
Medmonitor
COVID-19 Pill Approval and More Updates

Molnupiravir, Paxlovid, and AZD7442 have shown promise in Phase 3 trials.

Read More →
This Month's Must Read
The Long Haul: Chronic Health Complications of COVID-19

Those previously infected by the virus may face long-term health complications.

Read More →
Clinical Insights
Can Virtual Reality Help with Pain Management?

A new study found that VR sessions averaged a 40% reduction in pain and decreased opioid use.

Read More →
Legislation & Policy
Federal Judges Try to Block Vaccine Mandates

Rulings from U.S. District Courts have impeded vaccine requirements among certain workers.

Read More →
COVID-19 Developments
FDA Authorizes COVID-19 Booster Shots for All Adults

All adults may now receive a booster shot of any COVID-19 vaccine.

Read More →
Medmonitor
FDA Approves Zimhi and Seglentis

A new naloxone drug and a new opioid-NSAID combination.

Read More →
This Month's Must Read
Sickness and Society: The Future of Infectious Disease in the Workplace

Strategies for a safer, healthier workforce amid COVID-19 and beyond.

Read More →
COVID-19 Developments
FDA Authorizes Booster Shots for Moderna and J&J Vaccines

All COVID-19 vaccines now have emergency use authorization for a booster dose.

Read More →
Marijuana Updates
Cannabis in the Workplace on the Rise

One-third of employees have witnessed cannabis use during work hours.

Read More →
Industry Trends
Texas Telemedicine Report

Pre-pandemic, 951 claims received telemedicine, jumping to 21,000 during the pandemic.

Read More →
Healthe Developments
Healthesystems at WCI & SAWCA

Visit Healthe at WCI booth #913! Plus, a recap of a SAWCA roundtable, featuring Sandy Shtab.

Read More →
Medmonitor
New Drugs, Generics, and a COVID-19 Treatment Update

A new migraine medication, various generics, and more.

Read More →
This Month's Must Read
The Long Haul: Chronic Health Complications of COVID-19

Long-term health impacts of COVID-19 can complicate claims

Read More →
Clinical Insights
Topical Analgesics See Increase in Utilization

A WCRI study found that in some states 17% of workers receive topical analgesics.

Read More →
Industry Trends
Take the 2021 Workers’ Comp Industry Insights Survey

Take our survey and share your thoughts on where the industry is headed.

Read More →
Healthe Developments
Healthe Leaders to Speak at Upcoming Virtual Conferences

Take part in our virtual speaking sessions at PRIMA and Comp Laude!

Read More →
Medmonitor
FDA Approves Pfizer COVID-19 Vaccine, Booster Shots on the Way

The Pfizer vaccine receives full FDA approval, while a new EUA authorizes booster shots for certain populations.

Read More →
This Month's Must Read
Applying AI to Leverage the Value of Unstructured Claims Data

Healthe’s Director of Enterprise Analytics discusses in WorkCompWire how natural language processing can assist with claim review, population management, and more.

Read More →
Clinical Insights
WCRI Publishes Report on Off-Label Gabapentinoid Use

Less than 1% of gabapentin prescriptions were prescribed for an FDA-approved diagnosis.

Read More →
Legislation & Policy
White House Issues Vaccine Mandate

All federal employees are impacted, as are companies with 100 or more employees.

Read More →
Healthe Developments
Connect with Healthe at the 2021 National Comp Conference

Join our educational session on infectious disease safety in the workplace, and don’t miss a chance to take part in our industry survey!

Read More →
Medmonitor
New Generic Approvals

The FDA approved first-time generics for Xeljanz, two COPD medications, and more.

Read More →
This Month's Must Read
In Claims Management, Centralized Data Means Empowered Decisions

Healthe’s Director of Product Management explains how centralized data helps claims professionals.

Read More →
Clinical Insights
How Opioid Policy Impacts Opioid Utilization and Disability

A new WCRI report explores the impact recent opioid legislation has had on injured worker care.

Read More →
COVID-19 Developments
The Early Impact of COVID-19 on Workers’ Comp Claims

Another WCRI report looks at non-COVID-19 claims with injuries in the first two quarters of 2019 and 2020.

Read More →
Healthe Developments
Clinical Minute Video Series

Not enough time for white papers or industry reports? Check out our Clinical Minute videos!

Read More →
Medmonitor
FDA and CDC: Vaccinated Adults Will Not Need COVID-19 Booster Shots

A joint statement announces that at this time, vaccinated adults are protected from the Delta variant.

Read More →
This Month's Must Read
Home Alone: The Mental Health Impact of Working from Home

Extensive isolation and unique stressors may impact the mental health of remote workers.

Read More →
Clinical Insights
AMA Updates Impairment Rating Guidelines for the First Time Since 2008

Changes center around improving the assessment of mental and behavioral impairment.

Read More →
Legislation & Policy
More Recreational Marijuana Legalization, More Positive Workplace Drug Tests

Connecticut legalizes recreational use, and NCCI expects even more states to follow suit.

Read More →
Healthe Developments
Silvia Sacalis to Join Panel Presentation at Florida RIMS Conference

Join our VP of Clinical Services on July 29th for a discussion on care and program considerations for underrepresented populations.

Read More →
Medmonitor
FDA Approves First New Weight Loss Drug Since 2014, Issues EUA for COVID-19 Antibody

Wegovy (semaglutide) and sotrovimab will soon be available.

Read More →
This Month's Must Read
Empowering the Patient as a Mitigator of Claims Complexity

How to leverage the patient’s influence over care outcomes.

Read More →
Clinical Insights
Interstate Variation and Trends in Workers’ Comp Drug Payments

A new flash report from the WCRI highlights trends in drug utilization.

Read More →
Legislation & Policy
Mental Health Injuries Gain Momentum in Workers’ Comp

Corrections officers in Nebraska benefit from a new law; will healthcare workers in Connecticut join them?

Read More →
Healthe Developments
5 Ways We’re Innovating the Digital Experience for Claims Professionals

Check out Healthe’s latest featured article with WorkCompWire

Read More →
Healthe Developments
Silvia Sacalis to Join Panel Presentation at FERMA 2021

Join our VP of Clinical Services on July 15th for a discussion on underrepresented populations in workers' comp.

Read More →
Medmonitor
FDA Approves Kloxxado for Opioid Overdose

A new 8 mg naloxone nasal spray will soon be available, which is the largest naloxone dose approved by the FDA to date.

Read More →
This Month's Must Read
RxInformer Summer 2021 Edition Now Available

The latest issue of Healthesystems’ biannual clinical journal covers trending and influential topics in workers’ comp.

Read More →
Healthe Developments
Healthe Leaders in the Media

Our VP of Clinical Services comments on opioid alternatives, and our AVP of Advocacy & Compliance discusses social media in the workplace.

Read More →

Workers’ Comprehensive

News and views in workers’ comp
Important news in workers’ comp delivered to your inbox
Subscribe
Back to Top
lockenvelopephone-handsetcrossmenucross-circle